Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheet

v3.5.0.2
Condensed Balance Sheet - USD ($)
Jun. 30, 2016
Dec. 31, 2015
Current Assets:    
Cash and cash equivalents $ 7,877,995 $ 10,199,440
Marketable securities 11,519,899 13,240,086
Prepaid expenses and other current assets 996,083 1,221,818
Total Current Assets 20,393,977 24,661,344
Security Deposits 30,785 30,785
Equipment, Net 105,358 112,900
Total Assets 20,530,120 24,805,029
Current Liabilities:    
Accounts payable and accrued expenses 1,794,647 2,661,298
Deferred Research and Development Arrangement 487,500 525,000
Other Liabilities 92,595 104,020
Warrant Liabilities 2,340,978 2,739,163
Total Liabilities 4,715,720 6,029,481
Commitments and Contingencies (note 14)
Stockholders' Equity:    
Preferred stock, par value $0.0001, 100,000,000 authorized shares, none issued and outstanding
Common stock, par value $0.0001, 500,000,000 authorized shares, 213,233,785 and 197,413,785 issued and outstanding 21,323 19,741
Additional paid-in capital 127,422,480 124,490,712
Accumulated other comprehensive income (loss) 2,327 (18,041)
Accumulated deficit (111,631,730) (105,716,864)
Total Stockholders' Equity 15,814,400 18,775,548
Total Liabilities and Stockholders' Equity $ 20,530,120 $ 24,805,029